Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial)

INTRODUCTION: Atrial fibrillation (AF), with a prevalence of 2%, is the most common cardiac arrhythmia. Catheter ablation (CA) has been documented to be superior to treatment by antiarrhythmic drugs (AADs) in terms of sinus rhythm maintenance. However, in obese patients, substantial weight loss was...

Descripción completa

Detalles Bibliográficos
Autores principales: Osmancik, Pavel, Havránek, Štěpán, Bulková, Veronika, Chovančík, Jan, Roubíček, Tomáš, Heřman, Dalibor, Čarná, Zuzana, Tuka, Vladimír, Matoulek, Martin, Fiala, Martin, Jiravský, Otakar, Stregl-Hruskova, Sylvie, Latiňák, Adam, Kotryová, Jiřina, Jarkovský, Jiří
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204431/
https://www.ncbi.nlm.nih.gov/pubmed/35705334
http://dx.doi.org/10.1136/bmjopen-2021-056522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204431/
https://www.ncbi.nlm.nih.gov/pubmed/35705334
http://dx.doi.org/10.1136/bmjopen-2021-056522

Ejemplares similares